b r i e f c o m m u n i c at i o n s
The development of technologies for the in vitro amplification of abnormal conformations of prion protein (PrP Sc ) has generated the potential for sensitive detection of prions. Here we developed a new PrP Sc amplification assay, called realtime quaking-induced conversion (RT-QUIC), which allows the detection of ≥1 fg of PrPSc in diluted Creutzfeldt-Jakob disease (CJD) brain homogenate. Moreover, we assessed the technique first in a series of Japanese subjects and then in a blind study of 30 cerebrospinal fluid specimens from Australia, which achieved greater than 80% sensitivity and 100% specificity. These findings indicate the promising enhanced diagnostic capacity of RT-QUIC in the antemortem evaluation of suspected CJD.
Transmissible spongiform encephalopathies, or prion diseases, are characteristically associated with the accumulation of PrP Sc in the central nervous system through autocatalytic conversion of normal cellular PrP (PrP c ) into replicate misfolded isomers 1, 2 . Despite a few other reported markers 3, 4 , PrP Sc remains the best characterized and most reliable marker of prion disease.
Definitive antemortem confirmation of CJD requires the detection of PrP Sc in biopsy specimens, the practice of which is discouraged because it is invasive and poses risks to health care personnel. Recently, however, in vitro PrP Sc amplification techniques, including protein misfolding cyclic amplification [5] [6] [7] , the amyloid seeding assay 8 and QUIC, have been reported to enable the direct and highly sensitive detection of PrP Sc in various tissues, including cerebrospinal fluid (CSF). QUIC assays involve the use of soluble recombinant PrP (rPrP-sen) as a substrate, which is seeded with PrP Sc and then subjected to intermittent automated shaking. This technique can be performed more easily than the protein misfolding cyclic amplification, which requires repeated sonication. Previous studies have shown that QUIC assays correctly discriminate between normal and scrapie-infected CSF samples in both hamster and sheep prion disease models 9, 10 . However, ultrasensitive PrP Sc detection in CSF from subjects with CJD has not yet been accomplished. Accordingly, we further refined the QUIC assay to improve its sensitivity and practicability and then applied the technique in a blind pilot study to detect PrP Sc in CJD CSF specimens.
Given that a correlation between protease-resistant rPrP aggregate (rPrP-res) abundance and thioflavin T (ThT) fluorescence had been shown previously 7 , we sought to determine the relative kinetics of rPrP-res formation by monitoring levels of ThT fluorescence in the QUIC assay. This was intended to minimize the time needed to detect rPrP-res. We first tested whether PrP Sc -dependent rPrP-res (rPrP-res Sc ) formation could be induced in a microplate reader with intermittent shaking. We used human rPrP-sen (rHuPrP-sen) and a 10 −7 dilution of CJD (molecular subtype MM1) brain homogenate as the substrate and seed, respectively. We conducted QUIC reactions at various concentrations (0, 0.25, 0.5 and 1.0 M) of guanidine-HCl (GdnHCl), because it has been shown that GdnHCl greatly enhances conversion of PrPsen to PrP-res in cell-free conversion reactions 11 . Unexpectedly, we observed positive PrP Sc -dependent ThT fluorescence within 24 h, both in the presence and in the absence of GdnHCl (Fig. 1a) . In contrast, the negative control reactions without seed and in the absence of GdnHCl resulted in no increase in ThT fluorescence over 24 h; however, de novo formation of rPrP-res (rPrP-res spon ) was rapidly induced in the presence of GdnHCl when shaking was added (Fig. 1a,b) . These results indicate that shaking accelerates PrP Sc -dependent rPrP-res Sc formation even without GdnHCl (Supplementary Fig. 1 ), albeit with a lower peak of fluorescence.
Shaking is thought to cause partial unfolding of a portion of rPrP-sen by increasing the air-water interface 12 . Moreover, shaking enhances the interaction between rPrP-sen and PrP Sc and promotes the fragmentation of rPrP-res polymers 13 . It is generally accepted that the energetic barrier of seed-dependent fibril formation and elongation is lower than that of spontaneous fibril formation, which first requires nucleation as the rate-limiting step 14 . The partial unfolding of rPrP-sen by shaking seems to be more heterogeneous than that facilitated by a denaturant such as GdnHCl, perhaps because the air-water interfaces created by shaking are unequally distributed Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion b r i e f c o m m u n i c at i o n s in solution. We found that the addition of GdnHCl to QUIC reactions leads to an increase in the nucleation rate, and increased spontaneous fibril formation. The early appearance of rPrP-res spon decreases the specificity of QUIC, because ThT fluorescence cannot distinguish between rPrP-res Sc and rPrP-res spon . Therefore, we chose not to use GdnHCl in subsequent analyses.
To further optimize the conditions, we examined the effects of pH, as well as of the concentrations of rHuPrP-sen and salt on QUIC reactions in GdnHCl-free conditions with shaking ( Fig. 1c-e and Supplementary Fig. 2 ). After assessment, we successfully established a method for the real-time monitoring of the kinetics of rPrP fibril formation seeded with CJD brain homogenate (see Supplementary Methods), without the generation of rPrP-res spon and designated the assay RT-QUIC.
To determine the minimum amount of PrP Sc detectable by RT-QUIC, we diluted CJD brain homogenate (MM1 and MM2) serially with artificial CSF (A-CSF) and used these dilutions to seed the reactions. We observed increased PrP Sc -dependent ThT fluorescence within 48 h in more than half the replicates of CJD brain homogenate, with dilutions ranging from 10 −5 to 10 −9 ( Fig. 1f and Supplementary  Table 1 ). With 10 −10 brain homogenate dilutions, we observed a marginally lower rate of positive reactions, and 10 −11 dilutions of the CJDbrain homogenates produced no ThT fluorescence response ( Fig. 1f  and Supplementary Table 1) . The negative controls seeded with 10 −5 and 10 −7 dilutions of non-CJD brain homogenate or A-CSF alone (no seed) did not produce an increase in the fluorescence (Fig. 1f  and Supplementary Table 1) . The 10 −9 dilutions of MM1 and MM2 CJD brain homogenate contained approximately 0.8 and 1.9 fg of PrP Sc , respectively, according to our estimation (data not shown). Consequently, the results indicate that this assay consistently enables us to detect more than or equal to about 1 fg of PrP Sc in the diluted CJD brain homogenates within 48 h. Moreover, the fact that there was no rPrP-res spon formation under the conditions used implies a lower and acceptable risk of false-positive reactions. Whether the RT-QUIC has the same sensitivity to CJD brain homogenate with 129MV or 129VV as 129MM remains to be determined.
CSF is routinely used in the evaluation of central nervous system disorders and presumably contains more PrP Sc and fewer impurities than blood. This prompted us to compare the RT-QUIC seeding activity in CSF samples from subjects with CJD and subjects without CJD but with other neurodegenerative diseases. For the pilot study, we initially tested CJD CSF samples from 18 definite cases of CJD in Japan ( Table 1 ) and 35 non-CJD controls from subjects with other neurodegenerative diseases (Supplementary Table 2 ). We saw a minimal ThT fluorescence increase in the controls, with no false positives in the assay. In contrast, increased PrP Sc -dependent fluorescence was seen in at least one of four replicates in 15/18 (83.3%) of the CJD CSF samples ( Table 1 and Supplementary Table 3) .
To further confirm the reliability of RT-QUIC, we conducted a blind trial using 30 CSF samples from the Australian National CJD Registry and 155 CSF samples containing 25 probable cases of CJD and 130 cases of other neurological diseases obtained in Japan. In the Australian samples, we were able to detect PrP Sc in 14/16 (87.5%) definite CJD CSF samples, as opposed to 0/14 of the non-CJD controls ( Table 1, Supplementary Fig. 3 and Supplementary Table 3) . It should be noted that 3/4 129VV and 2/2 129MV cases were positive by RT-QUIC. a CJD can be divided into six molecular subtypes on the basis of whether methionine (M) or valine (V) is present at codon 129 of the gene encoding prion protein combined with the profile of PrP Sc (type 1 or type 2) as determined by western blotting 17 . b Amounts of the γ-isoform of 14-3-3 protein in CSF were determined by western blotting with a polyclonal antibody specific for the γ-isoform of the 14-3-3 protein 18 (+, positive reaction; −, negative reaction). c RT-QUIC was performed as described in the Supplementary Methods. The number of positive reactions over the number of replicates is shown in parentheses. Samples with at least one positive reaction were defined as +, representing a positive result in the RT-QUIC. d The final diagnosis was made by the Australian National CJD Registry. e Amounts of 14-3-3 protein (all isoforms) in CSF were determined by western blotting. f Additional atypical bands were observed. g Kinetics graphs are provided in Supplementary Figure 3 . Subjects or their families agreed with the aims and role of our research and gave appropriate informed consent. The investigation protocol was approved by the Ethics Committee of Nagasaki University Hospital (ID: 10042823), and the study was registered with the University Hospital Medical Information Network (ID: UMIN000003301). sCJD, sporadic Creutzfeldt-Jakob disease; iCJD, iatrogenic Creutzfeldt-Jakob disease; PN/MC, paraneoplastic/metastatic cancer; ICD, inflammatory central nervous system disorder; DLB/PD, dementia with Lewy bodies/Parkinson's disease; AD, Alzheimer's disease; ND, not determined.
